+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
All Ages
FEMALE
Healthy Volunteers
ID06379425

Evaluating Preoperative Opioid-free Multimodal Pain Relief to Speed Bladder Function Recovery After Minor Urogynecologic Surgeries

Led by Northwell Health · Updated on 2026-10-05

70

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

This trial evaluates the effect of preoperative opioid-free analgesia on the time it takes for patients to begin a trial of void after same-day minor urogynecologic surgeries. The study compares two approaches giving acetaminophen alone versus a combination of acetaminophen, celecoxib, and gabapentin. Researchers aim to see if adding these medications reduces the time to trial of void, improving recovery after surgery. Participants will be randomized to receive either a single dose of 1000 mg acetaminophen alone or a combination of 1000 mg acetaminophen, 400 mg celecoxib, and 300 mg gabapentin orally before their surgery. This is a crossover study where each participant receives both treatments at different times. The surgeries involved include procedures like midurethral sling, bulking injections, and repairs performed at outpatient surgery centers. During the study, researchers will measure the time from surgery to the start of the active trial of void, tracking this over an average of two years. Participants will be monitored for adherence and safety, and their health status will be regularly assessed. The study aims to provide insights into pain management without opioids, focusing on recovery speed and postoperative outcomes in female patients undergoing urogynecologic surgeries.

CONDITIONS

Brief Title

Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here